• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-29c 通过靶向 SP1 保护体内和体外帕金森病模型中的炎症和细胞凋亡。

MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1.

机构信息

Department of Geriatric Neurology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

Clin Exp Pharmacol Physiol. 2020 Mar;47(3):372-382. doi: 10.1111/1440-1681.13212. Epub 2019 Dec 15.

DOI:10.1111/1440-1681.13212
PMID:31732967
Abstract

MicroRNAs (miRNAs) have been shown to have complicated implications in the pathogenesis of Parkinson's disease (PD). However, the role of miR-29c and the underlying mechanism in the development of PD remain not well understood. In this work, the MPTP-treated mice or MPP -intoxicated SH-SY5Y cells were established as an in vivo or in vitro PD model. Then the specific agomir of miR-29c was employed to examine its biological function on PD progress. We found that miR-29c was down-expressed but SP1 was high-expressed in substantia nigra pars compacta (SNpc) of MPTP-induced PD mice. Overexpression of miR-29c attenuated dopaminergic neuron loss and α-synuclein accumulation in SNpc of PD mice. Furthermore, the increments of pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) and TUNEL-positive apoptotic cells in MPTP-treated mice were ameliorated by miR-29c. Similarly, in SH-SY5Y cell models of PD, we also found that miR-29c inhibited inflammatory cytokine production, reduced apoptotic rate and suppressed pro-apoptotic regulator activity. In addition, the increased expression of SP1 in PD models was found to be inhibited by miR-29c. Luciferase reporter assay confirmed that SP1 was complementary with miR-29c. Knockdown of SP1 with siRNA restored α-synuclein accumulation, inflammation and apoptosis in MPP -induced SH-SY5Y cells. Collectively, this current work presents that miR-29c may directly target SP1 to protect against the neuroinflammatory and apoptotic responses in PD, providing a potential biomarker for PD diagnosis and treatment.

摘要

微小 RNA(miRNAs)在帕金森病(PD)的发病机制中具有复杂的影响。然而,miR-29c 在 PD 发展中的作用及其潜在机制仍未完全阐明。在这项工作中,采用 MPTP 处理的小鼠或 MPP 诱导的 SH-SY5Y 细胞作为体内或体外 PD 模型。然后,采用 miR-29c 的特异性激动剂来研究其对 PD 进展的生物学功能。我们发现,miR-29c 在 MPTP 诱导的 PD 小鼠黑质致密部(SNpc)中表达下调,而 SP1 表达上调。miR-29c 的过表达减轻了 PD 小鼠 SNpc 中多巴胺能神经元的丢失和α-突触核蛋白的积累。此外,miR-29c 改善了 MPTP 处理小鼠中促炎细胞因子(TNF-α、IL-1β 和 IL-6)和 TUNEL 阳性凋亡细胞的增加。同样,在 PD 的 SH-SY5Y 细胞模型中,我们还发现 miR-29c 抑制了炎症细胞因子的产生,降低了细胞凋亡率,并抑制了促凋亡调节剂的活性。此外,在 PD 模型中发现 SP1 的增加表达被 miR-29c 抑制。荧光素酶报告基因检测证实 SP1 与 miR-29c 互补。用 siRNA 敲低 SP1 可恢复 MPP 诱导的 SH-SY5Y 细胞中α-突触核蛋白的积累、炎症和凋亡。总之,本研究表明,miR-29c 可能通过直接靶向 SP1 来保护 PD 中的神经炎症和凋亡反应,为 PD 的诊断和治疗提供了一个潜在的生物标志物。

相似文献

1
MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1.miR-29c 通过靶向 SP1 保护体内和体外帕金森病模型中的炎症和细胞凋亡。
Clin Exp Pharmacol Physiol. 2020 Mar;47(3):372-382. doi: 10.1111/1440-1681.13212. Epub 2019 Dec 15.
2
MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.微小 RNA-124 调控 MEKK3 在帕金森病炎症发病机制中的表达。
J Neuroinflammation. 2018 Jan 12;15(1):13. doi: 10.1186/s12974-018-1053-4.
3
miR-29c-3p regulates TET2 expression and inhibits autophagy process in Parkinson's disease models.miR-29c-3p在帕金森病模型中调节TET2表达并抑制自噬过程。
Genes Cells. 2021 Sep;26(9):684-697. doi: 10.1111/gtc.12877. Epub 2021 Jul 27.
4
LINC00943 acts as miR-338-3p sponge to promote MPP-induced SK-N-SH cell injury by directly targeting SP1 in Parkinson's disease.在帕金森病中,LINC00943作为miR-338-3p的海绵,通过直接靶向SP1来促进MPP诱导的SK-N-SH细胞损伤。
Brain Res. 2022 May 1;1782:147814. doi: 10.1016/j.brainres.2022.147814. Epub 2022 Feb 3.
5
Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo.牛膝多肽在帕金森病模型中无论是在体外还是体内均能保护多巴胺能神经元免于凋亡。
Br J Pharmacol. 2018 Feb;175(4):631-643. doi: 10.1111/bph.14110. Epub 2018 Jan 6.
6
Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation.长链非编码 RNA HAGLROS 通过调节 miR-100/ATG10 轴和 PI3K/Akt/mTOR 通路激活调控帕金森病中的细胞凋亡和自噬。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2764-2774. doi: 10.1080/21691401.2019.1636805.
7
Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP Parkinson's disease models.转录因子 SP1 的抑制通过降低 MPTP/MPP 帕金森病模型中的 MAO B 活性产生神经保护作用。
J Neurosci Res. 2018 Oct;96(10):1663-1676. doi: 10.1002/jnr.24266. Epub 2018 Jul 13.
8
Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.在帕金森病模型中,京尼平苷通过阻断微小RNA-21/溶酶体相关膜蛋白2A的相互作用来降低α-突触核蛋白。
Brain Res. 2016 Aug 1;1644:98-106. doi: 10.1016/j.brainres.2016.05.011. Epub 2016 May 9.
9
miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.微小RNA-494-3p通过靶向沉默调节蛋白3来调控帕金森病体外和体内模型的进展。
Neurosci Lett. 2018 May 14;675:23-30. doi: 10.1016/j.neulet.2018.03.037. Epub 2018 Mar 19.
10
MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.MicroRNA-190 通过 Nlrp3 减轻 MPTP 诱导的帕金森病小鼠模型中的神经元损伤并抑制神经炎症。
J Cell Physiol. 2019 Dec;234(12):23379-23387. doi: 10.1002/jcp.28907. Epub 2019 Jun 24.

引用本文的文献

1
MicroRNAs and synaptic dysfunction in Parkinson's disease.帕金森病中的微小RNA与突触功能障碍
Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102673. doi: 10.1016/j.omtn.2025.102673. eCollection 2025 Sep 9.
2
MicroRNAs Modulating Neuroinflammation in Parkinson's disease.微小RNA对帕金森病神经炎症的调节作用
Inflammation. 2024 Aug 20. doi: 10.1007/s10753-024-02125-z.
3
Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson's Disease.利用细胞外 miRNA 特征识别具有 LRRK2 相关性帕金森病的患者。
J Parkinsons Dis. 2024;14(5):977-991. doi: 10.3233/JPD-230408.
4
Parkinson's Disease and MicroRNAs: A Duel Between Inhibition and Stimulation of Apoptosis in Neuronal Cells.帕金森病与 microRNAs:神经元细胞凋亡的抑制与刺激之博弈。
Mol Neurobiol. 2024 Nov;61(11):8552-8574. doi: 10.1007/s12035-024-04111-w. Epub 2024 Mar 23.
5
Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults.血液 microRNA 表达与多态性与老年人认知和生物标志物变化的关联。
J Prev Alzheimers Dis. 2024;11(1):230-240. doi: 10.14283/jpad.2023.99.
6
Non-Coding RNAs and Neurodegenerative Diseases: Information of their Roles in Apoptosis.非编码 RNA 与神经退行性疾病:它们在细胞凋亡中作用的信息。
Mol Neurobiol. 2024 Jul;61(7):4508-4537. doi: 10.1007/s12035-023-03849-z. Epub 2023 Dec 16.
7
Expression Profiles of Long Noncoding RNAs and Messenger RNAs in a Rat Model of Spinal Cord Injury.长链非编码 RNA 和信使 RNA 在大鼠脊髓损伤模型中的表达谱。
Comput Math Methods Med. 2023 Jan 19;2023:6033020. doi: 10.1155/2023/6033020. eCollection 2023.
8
Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives.朊病毒和朊病毒样神经退行性疾病中的表观遗传变化:最新进展、作为生物标志物的潜力和未来展望。
Int J Mol Sci. 2022 Oct 20;23(20):12609. doi: 10.3390/ijms232012609.
9
Regulation of CIRP by genetic factors of SP1 related to cold sensitivity.SP1 相关冷敏感遗传因素对 CIRP 的调控。
Front Immunol. 2022 Sep 16;13:994699. doi: 10.3389/fimmu.2022.994699. eCollection 2022.
10
Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson's disease.帕金森病中调节性非编码RNA与氧化应激之间的相互作用
Front Aging Neurosci. 2022 Aug 9;14:975248. doi: 10.3389/fnagi.2022.975248. eCollection 2022.